AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35709862 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR) with ASG neck score ≥5
Number of subjects: 171
Study 35709862 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR) with favorable neck morphology
Number of subjects: 171
Study 35709862 — intervention group
Group type: COMPARATOR
Intervention: Receiver operating characteristic analysis
Number of subjects: 171
Study 35709862 — intervention group
Group type: COMPARATOR
Intervention: Positive likelihood-ratio
Number of subjects: 171
Study 35709862 — intervention group
Group type: COMPARATOR
Intervention: Negative likelihood-ratio
Number of subjects: 171
Study 33683403 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonified action observation and motor imagery (AOMI)
Number of subjects: 19
Study 33683403 — intervention group
Group type: COMPARATOR
Intervention: Non-sonified action observation and motor imagery (AOMI)
Number of subjects: 19
Study 33683403 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory paired associative stimulation (aPAS) completed alone
Number of subjects: 19
Study 33683403 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory paired associative stimulation (aPAS) primed by practice block
Number of subjects: 19
Study 32443290 — intervention group
Group type: EXPERIMENTAL
Intervention: PLIF
Number of subjects: 143
Study 32443290 — intervention group
Group type: COMPARATOR
Intervention: TLIF
Number of subjects: 143
Study 32443290 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of PLIF and TLIF
Number of subjects: 143
Study 35866347 — intervention group
Group type: EXPERIMENTAL
Intervention: RM + PEEP−EIT
Number of subjects: 60
Study 35866347 — intervention group
Group type: COMPARATOR
Intervention: PEEP−EIT
Number of subjects: 60
Study 33866666 — intervention group
Group type: EXPERIMENTAL
Intervention: Test toothpaste containing natural ingredients (clove, aloe vera, amla, neem, tulsi, honey) with zinc salts and fluoride
Number of subjects: 180
Study 33866666 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste formulated with fluoride alone
Number of subjects: 180
Study 32289741 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0
Study 32289741 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide 60 mg
Number of subjects: 0
Study 35689278 — intervention group
Group type: EXPERIMENTAL
Intervention: New type of CPM machine for 2 weeks post-operative rehabilitation
Number of subjects: 126
Study 35689278 — intervention group
Group type: COMPARATOR
Intervention: Conventional CPM machine for 2 weeks post-operative rehabilitation
Number of subjects: 126
Study 35689278 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of CPM machines for 2 weeks post-operative rehabilitation
Number of subjects: 126
Study 33287271 — intervention group
Group type: EXPERIMENTAL
Intervention: L-band PALSAR-2
Number of subjects: 0
Study 33287271 — intervention group
Group type: COMPARATOR
Intervention: C-band Sentinel-1
Number of subjects: 0
Study 35730655 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mind-set induction
Number of subjects: 0
Study 35730655 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mind-set induction
Number of subjects: 0
Study 35730655 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mind-set induction)
Number of subjects: 0
Study 32871403 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade smoothie A
Number of subjects: 20
Study 32871403 — intervention group
Group type: EXPERIMENTAL
Intervention: Homemade smoothie B
Number of subjects: 20
Study 32871403 — intervention group
Group type: COMPARATOR
Intervention: Commercial smoothie
Number of subjects: 20
Study 35787426 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA
Number of subjects: 3175
Study 35787426 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA and PFOS (joint effect)
Number of subjects: 3175
Study 35787426 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOA and PFOS
Number of subjects: 3175
Study 35787426 — intervention group
Group type: COMPARATOR
Intervention: PFOS
Number of subjects: 3175
Study 33060436 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D3, 2000 IU/day for 6 months
Number of subjects: 120
Study 33060436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 32102108 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic alert for vitamin D assay orders
Number of subjects: 12368
Study 32102108 — intervention group
Group type: COMPARATOR
Intervention: No electronic alert for vitamin D assay orders (Control)
Number of subjects: 12368
Study 35094694 — intervention group
Group type: EXPERIMENTAL
Intervention: One meat-free, three meat options
Number of subjects: 2205
Study 35094694 — intervention group
Group type: EXPERIMENTAL
Intervention: Two meat-free, two meat options
Number of subjects: 2205
Study 35094694 — intervention group
Group type: EXPERIMENTAL
Intervention: Three meat-free, one meat option
Number of subjects: 2205
Study 35094694 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the availability of meat-free options
Number of subjects: 2205
Study 35094694 — intervention group
Group type: EXPERIMENTAL
Intervention: Altering the ratio of meat-free meals in university cafeteria
Number of subjects: 2205
Study 35094694 — intervention group
Group type: EXPERIMENTAL
Intervention: Menu change in 18 worksite cafeterias
Number of subjects: 2205
Study 34083338 — intervention group
Group type: EXPERIMENTAL
Intervention: Relating Therapy (RT) plus Treatment as Usual (TAU)
Number of subjects: 75
Study 34083338 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 75
Study 36383175 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab and glucocorticoids
Number of subjects: 209
Study 36383175 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoids only
Number of subjects: 209
Study 32981536 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg slow-release)
Number of subjects: 16
Study 32981536 — intervention group
Group type: COMPARATOR
Intervention: Control (inactive placebo)
Number of subjects: 16
Study 32351205 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmirtazapine 4.5 mg
Number of subjects: 457
Study 32351205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 457
Study 32351205 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmirtazapine 4.5 mg (in open-label extension)
Number of subjects: 457
Study 35960649 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (SSS, bupivacaine 0.5% + fentanyl)
Number of subjects: 133
Study 35960649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral transversus abdominis plane block (TAP, ropivacaine 0.375% + clonidine)
Number of subjects: 133
Study 35960649 — intervention group
Group type: COMPARATOR
Intervention: Systemic administration of lidocaine (SA, lidocaine 1%)
Number of subjects: 133
Study 34057096 — intervention group
Group type: EXPERIMENTAL
Intervention: Short pulse deep brain stimulation (spDBS) with 40μs pulse width
Number of subjects: 20
Study 34057096 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional deep brain stimulation (cDBS) with 60μs pulse width
Number of subjects: 20
Study 34057096 — intervention group
Group type: COMPARATOR
Intervention: DBS stimulation switched off (off DBS)
Number of subjects: 20
Study 34176847 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoplastic resin removable partial dentures (TR‐RPDs)
Number of subjects: 28
Study 34176847 — intervention group
Group type: COMPARATOR
Intervention: Metal‐clasp‐retained removable partial dentures (MC‐RPDs)
Number of subjects: 28
Study 33487259 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 300,000 IU vitamin D3
Number of subjects: 60
Study 33487259 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 36369266 — intervention group
Group type: EXPERIMENTAL
Intervention: DLDL-RF hybrid model
Number of subjects: 0
Study 36369266 — intervention group
Group type: COMPARATOR
Intervention: CNN-GRU model
Number of subjects: 0
Study 34530750 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 248
Study 34530750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 33358107 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 106
Study 33358107 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic Paravertebral Block (TPVB)
Number of subjects: 106
Study 33358107 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal Nerve Block (ICNB)
Number of subjects: 106
Study 32064725 — intervention group
Group type: EXPERIMENTAL
Intervention: CIN-Zn (756.6 μmol/L cinnamaldehyde and 70 μmol/L zinc)
Number of subjects: 58
Study 32064725 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT (1.6 mmol/L citral)
Number of subjects: 58
Study 32064725 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT-ISO (1.6 mmol/L citral and 1.3 mmol/L isopulegol)
Number of subjects: 58
Study 36036546 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR group (implantable loop recorder screening for AF)
Number of subjects: 6004
Study 36036546 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 6004
Study 36036546 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR group
Number of subjects: 6004
Study 36036546 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6004
Study 36036546 — intervention group
Group type: EXPERIMENTAL
Intervention: ILR group (participants without prior stroke)
Number of subjects: 6004
Study 34933717 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 70
Study 34933717 — intervention group
Group type: COMPARATOR
Intervention: Analgesic drugs
Number of subjects: 70
Study 35605426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous labetalol (20 mg; 40 mg; 80 mg; 80 mg; and 80 mg)
Number of subjects: 113
Study 35605426 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydralazine (10 mg, up to 5 doses)
Number of subjects: 113
Study 35605426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous labetalol
Number of subjects: 113
Study 35605426 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydralazine
Number of subjects: 113
Study 33709237 — intervention group
Group type: EXPERIMENTAL
Intervention: High suspension and low incision (HSLI) surgery
Number of subjects: 246
Study 33709237 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy
Number of subjects: 246
Study 32925039 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 132
Study 32925039 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 132
Study 32925039 — intervention group
Group type: COMPARATOR
Intervention: Health Education Control (HE)
Number of subjects: 132
Study 36302125 — intervention group
Group type: COMPARATOR
Intervention: ABI-H2158 (100, 300, or 500 mg QD or 300 mg BID)
Number of subjects: 93
Study 36302125 — intervention group
Group type: COMPARATOR
Intervention: ABI-H2158 (5-500 mg single ascending dose)
Number of subjects: 93
Study 36302125 — intervention group
Group type: COMPARATOR
Intervention: ABI-H2158 (300 mg QD or BID for 10 days)
Number of subjects: 93
Study 36302125 — intervention group
Group type: COMPARATOR
Intervention: ABI-H2158 (300 mg QD for 14 days)
Number of subjects: 93
Study 33474705 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy
Number of subjects: 31
Study 35387759 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg Ursodeoxycholic acid (UDCA) for 6 months
Number of subjects: 967
Study 35387759 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 967
Study 34224554 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with reduced particle size (WB RPS), 20 g daily for 1 month
Number of subjects: 14
Study 34224554 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran with reduced particle size (WB RPS)
Number of subjects: 14
Study 34224554 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 14
Study 34674667 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate tablets titrated up to a maximum of 3 g bd (6 g total) for 12 weeks
Number of subjects: 43
Study 34674667 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 43
Study 32757595 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intervention
Number of subjects: 76
Study 32757595 — intervention group
Group type: COMPARATOR
Intervention: Ask, advise, refer (AAR)
Number of subjects: 76
Study 33650265 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic inflammatory response (SIR) biomarkers
Number of subjects: 4199
Study 33513734 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat-based complementary diet
Number of subjects: 0
Study 33513734 — intervention group
Group type: COMPARATOR
Intervention: Dairy-based complementary diet
Number of subjects: 0
Study 34740020 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV communication with alters currently enrolled in drug treatment
Number of subjects: 227
Study 34740020 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV communication with alters sharing drug preparation equipment
Number of subjects: 227
Study 34740020 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV communication with alters who are sex partners compared to kin
Number of subjects: 227
Study 34740020 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV communication with alters with increased trust
Number of subjects: 227
Study 34740020 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV communication with alters with daily/weekly interactions
Number of subjects: 227
Study 33256626 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural smoking cessation intervention
Number of subjects: 0
Study 33256626 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial Sequential Analysis
Number of subjects: 0
Study 34030123 — intervention group
Group type: EXPERIMENTAL
Intervention: Physically active lessons (intervention group, n = 34)
Number of subjects: 61
Study 34030123 — intervention group
Group type: COMPARATOR
Intervention: Control classes (control group, n = 27)
Number of subjects: 61
Study 36493792 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib plus endocrine therapy
Number of subjects: 5637
Study 36493792 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 5637
Study 34342620 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation and ventilator liberation protocol intervention
Number of subjects: 8843
Study 34342620 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8843
Study 36220716 — intervention group
Group type: EXPERIMENTAL
Intervention: 109 CFU BPZE1 via VaxINator device
Number of subjects: 50
Study 36220716 — intervention group
Group type: EXPERIMENTAL
Intervention: 109 CFU BPZE1 via tuberculin syringe
Number of subjects: 50
Study 36220716 — intervention group
Group type: EXPERIMENTAL
Intervention: 107 CFU BPZE1 via VaxINator device
Number of subjects: 50
Study 36220716 — intervention group
Group type: COMPARATOR
Intervention: Placebo via VaxINator device
Number of subjects: 50
Study 36220716 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 50
Study 33639116 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality with Nintendo Wii (VRWiiG)
Number of subjects: 29
Study 33639116 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (CPTG)
Number of subjects: 29
Study 32122821 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PCI IVUS assessment
Number of subjects: 603
Study 32122821 — intervention group
Group type: COMPARATOR
Intervention: No post-PCI IVUS assessment
Number of subjects: 603
Study 32122821 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tertile of LMS MSA
Number of subjects: 603
Study 32122821 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper tertile of LMS MSA
Number of subjects: 603
Study 36053841 — intervention group
Group type: EXPERIMENTAL
Intervention: Open lumbar spine fusion surgery
Number of subjects: 40
Study 36053841 — intervention group
Group type: COMPARATOR
Intervention: Narcotic medication
Number of subjects: 40
Study 32930952 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox (20 mg/kg)
Number of subjects: 28
Study 32930952 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-ANN model
Number of subjects: 28
Study 34430189 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral economic-based messages
Number of subjects: 0
Study 34430189 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34556006 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused group therapy (EFGT)
Number of subjects: 72
Study 32346962 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Tranexamic Acid (TXA) 250 mg twice daily
Number of subjects: 60
Study 32346962 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid (TXA)
Number of subjects: 60
Study 32346962 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Kligman's regimen
Number of subjects: 60
Study 35112779 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg once daily
Number of subjects: 1088
Study 35112779 — intervention group
Group type: COMPARATOR
Intervention: Acarbose 100 mg three times daily
Number of subjects: 1088
Study 35112779 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 1088
Study 35112779 — intervention group
Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 1088
Study 33012244 — intervention group
Group type: EXPERIMENTAL
Intervention: Descending Stair Exercise (DSE)
Number of subjects: 36
Study 33012244 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascending Stair Exercise (ASE)
Number of subjects: 36
Study 33012244 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 36
Study 616173591 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational-supportive self-care package
Number of subjects: 56
Study 616173591 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 56
Study 36215327 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital home exercise program (12-week duration, four exercises daily)
Number of subjects: 213
Study 36215327 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy (6 to 12 sessions depending on severity)
Number of subjects: 213
Study 32615162 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional nodal irradiation (RNI)
Number of subjects: 183
Study 35956337 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-rich, low-glycaemic meal replacement for 6 months
Number of subjects: 463
Study 35956337 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention alone (control group)
Number of subjects: 463
Study 33442937 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-normal saline (HNS)
Number of subjects: 99
Study 33442937 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 99
Study 32735225 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app group (n=25)
Number of subjects: 50
Study 32735225 — intervention group
Group type: COMPARATOR
Intervention: Paper-based diary group (n=25)
Number of subjects: 50
Study 32735225 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 34961658 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature based on preoperative multiparametric MRI features
Number of subjects: 234
Study 34961658 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics-based models
Number of subjects: 234
Study 34961658 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-defined extramural venous invasion (mrEMVI)
Number of subjects: 234
Study 32954628 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed tooth (Group 2)
Number of subjects: 35
Study 32954628 — intervention group
Group type: COMPARATOR
Intervention: Standard model tooth (Group 1)
Number of subjects: 35
Study 32354590 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous mepivacaine
Number of subjects: 100
Study 32354590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 100
Study 32354590 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic cream
Number of subjects: 100
Study 32354590 — intervention group
Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 100
Study 35373862 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA fish oil supplement (1491 mg DHA + 351 mg eicosapentaenoic acid per day)
Number of subjects: 72
Study 35373862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 34254211 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta
Number of subjects: 1326
Study 34254211 — intervention group
Group type: COMPARATOR
Intervention: Follitropin alfa
Number of subjects: 1326
Study 34254211 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta (fresh cycles)
Number of subjects: 1326
Study 34254211 — intervention group
Group type: COMPARATOR
Intervention: Follitropin alfa (fresh cycles)
Number of subjects: 1326
Study 34254211 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta (frozen cycles)
Number of subjects: 1326
Study 34254211 — intervention group
Group type: COMPARATOR
Intervention: Follitropin alfa (frozen cycles)
Number of subjects: 1326
Study 32880050 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI, 10 °C)
Number of subjects: 9
Study 32880050 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoneutral water immersion (TWI, 24 °C)
Number of subjects: 9
Study 32880050 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast water therapy (CWT, alternately 10 °C and 38 °C)
Number of subjects: 9
Study 32880050 — intervention group
Group type: COMPARATOR
Intervention: Active recovery only (ACT)
Number of subjects: 9
Study 34597280 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical treatment
Number of subjects: 0
Study 34597280 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 0
Study 33749041 — intervention group
Group type: EXPERIMENTAL
Intervention: DBB (Deproteinized Bovine Bone) with SA (Sandblasting + acid attack)
Number of subjects: 16